scispace - formally typeset
K

Kai Sen Tan

Researcher at National University of Singapore

Publications -  59
Citations -  4604

Kai Sen Tan is an academic researcher from National University of Singapore. The author has contributed to research in topics: Influenza A virus & Virus. The author has an hindex of 16, co-authored 57 publications receiving 3108 citations. Previous affiliations of Kai Sen Tan include Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.

TL;DR: The latest research progress of the epidemiology, pathogenesis, and clinical characteristics of COVID-19 are summarized, and the current treatment and scientific advancements to combat the epidemic novel coronavirus are discussed.
Journal ArticleDOI

Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia.

TL;DR: In this article, the authors showed that human NACHT, LRR, and PYD domains-containing protein 1 (NLRP1) is activated by 3C proteases (3Cpros) of enteroviruses, such as human rhinovirus (HRV), which directly cleaves human NLRP1 at a single site between Glu130 and Gly131.
Journal ArticleDOI

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.

TL;DR: NECs differentiated from healthy nasal-tissue derived stem cells are established as a suitable model for the ex-vivo study of SARS-CoV-2 mediated pathogenesis, and a non-essential role for ORF8 is demonstrated in modulating host gene expression and cytokine production from infected cells.
Journal ArticleDOI

In vivo and in vitro studies on the antiviral activities of viperin against influenza H1N1 virus infection.

TL;DR: Although the in vitro studies demonstrated the ability of viperin to restrict influenza H1N1 virus replication, the viperIn-deficient mouse model indicated that absence of vipersin enhanced neither the viral load nor pulmonary damage in the lungs of infected mice, suggesting that further investigations that exploit the antiviral mechanisms of v Viperin as prophylaxis are still warranted.